NanoSphere Health Sciences (CSE:NSHS; OTC:NSHSF) has developed a newly-patented delivery technology that increases the bioavailability and bioactivity of its Evolve line of gel-like cannabinoids for the treatment of pain, inflammation and anxiety.
NanoSphere Health Sciences and Vertical Companies™ Form Strategic Partnership to Launch Evolve Products in Arizona & California
Licensing agreement will bring the patented NanoSphere Delivery System™ to the world’s largest legal market this summer
DENVER (May 2, 2018)– NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), parent company of cannabis brand Evolve Formulas, has joined forces with Vertical™, the largest fully integrated company in the legal medical cannabis industry, to launch Evolve’s growing product line in Arizona and California this summer.
New product formula utilizes CBD, THC and resveratrol for rapid repair and rejuvenation with nanotechnology for the ultimate therapy
DENVER, April 30, 2018 /PRNewswire/ -- NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), parent company of cannabis brand Evolve Formulas, today announced the latest addition to its cannabis product line-up using NanoSphere Health's patented delivery technology. The new Transdermal NanoSerum™ CBD pen is now available with a desirable 10:1 ratio of CBD:THC. The product will be in Colorado dispensaries starting in mid-May.
In only a brief period of time, the cannabis industry has achieved remarkable progress, bringing to market safer, more intelligent product offerings, backed by research and designed to not only enhance but transform the consumer experience. Science and biotechnology companies are increasingly breaking down barriers, fighting the stigma, and making important strides toward gaining widespread acceptance of marijuana as a legitimate medical tool and, more specifically, as a trusted alternative to harmful and addictive prescription opiates.
Chief Science Officer, Dr. Kaufman makes some thoughtful arguments about the speed of transdermal delivery.
However, these mainstream methods of consuming and administering marijuana are potentially problematic for a number of reasons. Fortunately, innovative new administration methods that deliver cannabinoids through the skin—using transdermals—or through the mucosa in the nose and mouth—using intranasal and intraoral products—are on the rise, offering promising solutions to the common issues associated with traditional cannabis delivery.
Dear Valued Shareholders,
I would like to take this opportunity to outline the details of a significant milestone for NanoSphere Health Sciences and how this will impact the future of the company. We have been granted our landmark patent for the NanoSphere Delivery System™, which means we now officially have ownership of the biggest advancement in non-invasive medical delivery in over 25 years. A major thank you is in order to everyone who has come on this journey with us, especially those who have been here since the very beginning—from the challenging years of R&D through the pivotal point of commercialization to now, as we realize this new reality and lay the foundation for the bright future of this business.
NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform
Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery system
Denver (March 27, 2018) – NanoSphere Health Sciences Inc (CSE: NSHS) (OTC: NSHSF) is pleased to announce that its flagship subsidiary, NanoSphere Health Sciences, LLC, has been granted Patent No. 9,925.149—which covers the core technology behind the production of the NanoSphere Delivery System™—by the United States Patent and Trademark Office.
As research into cannabis has grown, the demand for new and innovative delivery methods has exploded. NanoSphere Health Sciences (NSHS.CN) (CSE:NSHS) (CNSX: NSHS) is disrupting the space through its innovative delivery systems, which include transdermal, intraoral, and intranasal applications. The Evolve NanoSerum won the 2017 Dope Cup Award for Best Transdermal and the company recently signed an agreement to license their cannabis technology to the state of California.
CFN sat down with NanoSphere Health Sciences COO David Sutton at the recent Seed to Sale show in Denver Colorado.
Tune in to @MarijuanatimesX latest #podcast episode to hear President & COO @davidrsutton discuss the benefits of our delivery system
03-08-2018 Video News – The Marijuana Times Show
Joe Klare discusses final regulations for recreational marijuana in Massachusetts, a case in Texas involving a father giving his autistic daughter medical cannabis and an interview with David Sutton from NanoSphere Health Sciences.
Evolve Formulas’ Transdermal NanoSerum™ Continues to Expand
DENVER (March 7, 2018) – NanoSphere Health Sciences Inc. (CSE: NSHS/ OTC: NSHSF) cannabis product brand Evolve Formulas is now stocked in over 100 dispensaries throughout Colorado. The company’s pioneering product, Transdermal NanoSerum™, uses the NanoSphere Delivery System™ developed by the biotechnology firm to allow cannabis to enter systemic circulation within ten minutes for fast-acting, effective relief from pain, inflammation and anxiety. This milestone comes on the back of continuous growth, with the company recently signing a licensing agreement in California.
20 Dose-Dispenser Provides Discrete and Hassle-Free Option for Evolve Customers
DENVER (DATE) – Back by popular demand, the 5ml Transdermal NanoSerum™ pen is now available in more than 90 dispensaries throughout Colorado. This compact product size contains 20 doses of NanoSerum™, each with 10mg of THC. The game-changing Evolve Formulas product immediately penetrates the skin following application to deliver direct-focused relief from pain, inflammation and anxiety.
Innovative Biotech Company Teams Up With Dispensary and Charity Partners for Community Event
Denver (Feb 26, 2018) - Evolve Formulas supported one of Denver’s most vulnerable populations last week through a unique charity initiative. A Kitchen One-For-One food truck served up a variety of delicious menu items to Evolve customers at the Lightshade - Peoria dispensary. For every meal provided to Lightshade employees and customers, a meal will go to those in need. Approximately 800 meals will be provided to homeless members of the local community as a result of the initiative on Saturday, March 3.
Evolve hosts Charity Food Truck Lunch at
LIGHTSHADE - PEORIA Dispensary
Evolve Formulas’ Dispensary Luncheon
Feeds Homeless With One-For-One System
What: Join Evolve Formulas, a brand of NanoSphere Health Sciences, for a special cannabis dispensary lunch in aid of homelessness charity Kitchen One for One! This Evolve Formulas’ lunch will provide free meals at Lightshade - Peoria to show their appreciation for their key dispensary partner, for Lightshade customers and to share the love with a great cause.
A food truck serving a mouth-watering menu of tacos, nachos, and quesadillas will be on site at Lightshade - Peoria, offering a free meal to the homeless for each meal served.
Free lunch will be provided to anyone who makes a Lightshade purchase during the allocated time and to Lightshade employees from any location - so come down to kick off your weekend with free food and the best of cannabis products.
Be sure to check out the Evolve Transdermal NanoSerum™, in stores at Lightshade now. NanoSerum(™) is the first and only cannabis product that travels across the skin membrane and blood-brain barrier for fast, effective results. It’s discreet, with no patches, for consistent, precision-metered doses that you can use anytime, anywhere.
When: Friday, February 16, 4:00pm - 6:00pm
Where: Lightshade - Peoria
11975 E. 40th Ave.
Denver, CO 80239
Take I-70 to the Peoria exit
For more information or to schedule a media interview, please contact Emily Kielthy at 646-695-7045 or email@example.com.
NanoSphere Health Sciences Inc. (Formerly Corazon Gold Corp.) Announces Name Change, CSE Listing And Conversion Of $5.9m In Subscription Receipts
DENVER, Dec. 4, 2017 /PRNewswire/ -- NanoSphere Health Sciences Inc. (CSE: NSHS) ("NanoSphere") (formerly Corazon Gold Corp.) is pleased to announce a name change and listing on the Canadian Securities Exchange (the "CSE"), effective today. NanoSphere's shares will commence trading tomorrow, December 5, 2017, under the symbol "NSHS".
Corazon Gold Corp. (the “Company”) and NanoSphere Health Sciences, LLC (“NanoSphere”) are pleased to announce the closing of the Company’s private placement (the “Offering”) for gross proceeds of $5,905,685, and the completion of the Company’s acquisition (the “Acquisition”) of NanoSphere. Based upon the CSE’s conditional listing approval, the Company will make its final submission for CSE listing in short order, and concurrently with its listing on the CSE will change its name to “NanoSphere Health Sciences Inc.” and effect a de-listing from the TSX Venture Exchange.
On August 20th, Evolve’s NanoSerum™ won the 2017 Dope Cup award from Dope Magazine for best transdermal. Dope Magazine is distributed in every dispensary in Colorado, Arizona, California, Oregon, Washington, and Nevada. This is a very respected award and past winners have done on to be dominate players in their categories. Product evaluations were completed by third-party company called Trichome Institute. Trichome conducted double-blind testing on Evolve’s serum to evaluate texture, scent, uniqueness, and packaging. We scored a 92.6 out of 100, one of the highest scores out of all categories. Trichome Institute said, “This is a fantastically packaged product that is clearly labeled with super simple dosing instructions. The pen is easy use and the gel was the perfect consistency and scent. Love it!” Trichome sets the highest standards of science, education, and certification in the cannabis industry.
“Building a business and launching a product is already a big accomplishment, but to turn out a product that wins an award in such a short period of time is really amazing”, says Dave Tran, the owner of Dope Magazine.
Winning such an accredited award in the cannabis industry is a huge deal. We are very proud of this accomplishment and expect many more awards in the future.